v3.26.1
CONDENSED BALANCE SHEETS - USD ($)
Jun. 30, 2026
Dec. 31, 2025
Current Assets    
Cash $ 1,126,887 $ 0
Due from Sponsor $ 1,095  
Other Receivable, after Allowance for Credit Loss, Current, Related Party [Extensible Enumeration] Related Party [Member] Related Party [Member]
Prepaid expenses $ 47,486 $ 19,229
Prepaid insurance 90,781  
Total Current Assets 1,266,249 19,229
Deferred offering costs   157,363
Long-term prepaid insurance 57,268  
Marketable securities held in Trust Account 166,594,389  
TOTAL ASSETS 167,917,906 176,592
Current Liabilities    
Accrued expenses 197,454 30,480
Accrued offering costs $ 75,000 130,988
Promissory note - related party   $ 49,267
Notes Payable, Current, Related Party [Extensible Enumeration] Related party Related party
Total Current Liabilities $ 272,454 $ 210,735
Deferred underwriting fee payable 6,580,000  
TOTAL LIABILITIES 6,852,454 210,735
Commitments and Contingencies (Note 7)
Shareholders' Deficit    
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding as of June 30, 2026 and December 31, 2025
Additional paid-in capital   24,569
Accumulated deficit (5,529,401) (59,143)
Total Shareholders' Deficit (5,528,937) (34,143)
TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS' DEFICIT 167,917,906 176,592
Class A ordinary shares subject to possible redemption    
Current Liabilities    
Class A ordinary shares subject to possible redemption, 16,450,000 shares and 0 shares at a redemption value of $10.13 and $0 per share as of June 30, 2026 and December 31, 2025, respectively 166,594,389  
Common Class A    
Shareholders' Deficit    
Ordinary shares 53  
Common Class B    
Shareholders' Deficit    
Ordinary shares [1] $ 411 $ 431
[1] Includes 200,000 Class B ordinary shares, $0.0001 par value, subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 6). On February 25, 2026, the Company consummated the closing of an additional 1,450,000 Units in connection with a partial exercise of the underwriters’ over-allotment option, generating gross proceeds of $14,500,000 (see Note 1). On April 4, 2026, the remaining 200,000 Class B ordinary shares were surrendered pursuant to the expiration of the underwriters’ over-allotment option for no consideration.